Meeting
2021 ASCO Annual Meeting
Oncologists’ (ONCs) perceptions of tumor genomic profiling (TGP) and barriers to communicating secondary hereditary risk to African American (AA) patients.
Authors
Michael J. Hall
Fox Chase Cancer Center, Philadelphia, PA
Michael J. Hall , Sarah Bauerle Bass , Yana Chertock , Jesse A Brajuha , Paul D'Avanzo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10592)
DOI
10.1200/JCO.2021.39.15_suppl.10592
Abstract #
10592
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Training oncologists (Oncs) to conduct better informed discussions with African American (AA) cancer (CA) patients (pts) about tumor genomic profiling (TGP): Results of a randomized pilot trial of Gene Pilot Pro (GPP).
First Author: Michael J. Hall
Poster
2023 ASCO Annual Meeting
Characterizing medical mistrust (MM) in a socio-demographically diverse sample of patients with cancer.
First Author: Cindy Park
Poster
2019 Genitourinary Cancers Symposium
Percent genome alteration and outcomes after radical prostatectomy in African American men.
First Author: Farzana A Faisal
Poster
2018 ASCO Annual Meeting
Development of HOPE-Genomics: An IT platform for patient-directed cancer genome sequencing education and return of results.
First Author: Ilana Solomon